MiniMed Group Inc (MMED)

Currency in USD
18.34
+0.05(+0.27%)
Closed·
18.40+0.06(+0.33%)
·
MMED is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
17.9318.47
52 wk Range
10.6524.43
Key Statistics
Prev. Close
18.29
Open
18.47
Day's Range
17.93-18.47
52 wk Range
10.65-24.43
Volume
4.74M
Average Volume (3m)
6.62M
1-Year Change
-
Book Value / Share
12.89
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MMED Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
25.47
Upside
+38.86%
Members' Sentiments
Bearish
Bullish
ProTips
4 analysts have revised their earnings downwards for the upcoming period

MiniMed Group Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

12 Buy
3 Hold
1 Sell
Ratings:
16 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 25.47
(+38.86% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Rothschild Redburn
Buy30.00+63.58%-New CoverageOct 13, 2026
Jefferies
Hold22.00+19.96%-New CoverageOct 12, 2026
Mizuho
Buy28.00+52.67%26.00MaintainOct 08, 2026
Barclays
Hold22.00+19.96%-New CoverageOct 06, 2026
Truist Securities
Buy29.00+58.12%-New CoverageSep 24, 2026

MiniMed Group Inc Earnings Call Summary for Q1/2027

  • MiniMed Q1 FY2027 revenue rose 15.8% organically to $843M, beating internal expectations; stock jumped 5.06% to $21.29, near 52-week high.
  • Company raised FY2027 organic revenue growth guidance to ~10.5% from ~10%; maintained adjusted EBITDA margin target at ~16% for full year.
  • U.S. revenue grew 13.1% organically while international sales climbed 16.9%; new pump sales rose 7.7% to 34,000 units with U.S. up over 20%.
  • Adjusted EBITDA reached $83M with 9.9% margin (12.2% excluding temporary items); negative $90M free cash flow due to separation costs.
  • Key product milestones: MiniMed Flex Europe launch Nov 2027, Fit U.S. launch summer 2027, Vivera closed-loop algorithm H2 2027 pending FDA approval.
Last Updated: 09/01/2026, 09:48 PM
Read Full Transcript

Earnings

Latest Release
Sep 01, 2026
EPS / Forecast
0.17 / 0.18
Revenue / Forecast
843M / 808.09M
EPS Revisions
Last 90 days

MMED Income Statement

Compare MMED to Peers and Sector

Metrics to compare
MMED
Peers
Sector
Relationship
P/E Ratio
−16.4x−63.3x−0.3x
PEG Ratio
0.42−1.260.00
Price/Book
1.4x21.5x2.6x
Price / LTM Sales
1.6x4.8x2.9x
Upside (Analyst Target)
39.2%26.9%64.3%
Fair Value Upside
Unlock−27.5%9.2%Unlock

MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, such as insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D. The company’s platform includes Automated Insulin Delivery (AID) systems for glucose sensing and automated insulin dosing and administration for glycemic control and Smart Multiple Daily Injection (MDI) systems for self-administering insulin by manual injections, which include InPen, Simplera Sync, or Guardian 4 sensor, and wraparound applications and services. It also offers CareLink, a software platform that provides support for person with diabetes, their caretakers, and HCPS. MiniMed Group, Inc. was founded in 1983 and is headquartered in Northridge, California. MiniMed Group, Inc. operates as a subsidiary of Medtronic plc.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
14.49M5.15%257.95M
Other Institutional Investors
276.13M94.85%4.92B
Public Companies & Retail Investors
0.000.00%0.00
Total
290.62M100.00%5.17B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Medtronic plc89.86%252,813,3484,500,078
Massachusetts Financial Services Company2.96%8,334,738148,358

People Also Watch

128.7400
RBRK
+6.62%
95.41
MDT
-1.22%
53.41
PENG
+2.89%
110.82
CBRS
+1.73%
147.29
CRDO
-9.51%

FAQ

What Is the MiniMed (MMED) Stock Price Today?

The MiniMed stock price today is 18.34 USD.

What Stock Exchange Does MiniMed Trade On?

MiniMed is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for MiniMed?

The stock symbol for MiniMed is "MMED."

What Is the MiniMed Market Cap?

As of today, MiniMed market cap is 5.15B USD.

What Is MiniMed's Earnings Per Share (TTM)?

The MiniMed EPS (TTM) is -1.19.

When Is the Next MiniMed Earnings Date?

MiniMed will release its next earnings report on Dec 30, 2026.

From a Technical Analysis Perspective, Is MMED a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has MiniMed Stock Split?

MiniMed has split 0 times.

What is the current trading status of MiniMed (MMED)?

As of Oct 23, 2026, MiniMed (MMED) is trading at a price of 18.34 USD, with a previous close of 18.29 USD. The stock has fluctuated within a day range of 17.93 USD to 18.47 USD, while its 52-week range spans from 10.65 USD to 24.43 USD.

What Is MiniMed (MMED) Price Target According to Analysts?

The average 12-month price target for MiniMed is 25.47 USD, with a high estimate of 30 USD and a low estimate of 15 USD. 12 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +38.86% Upside potential.

What Is the MMED Premarket Price?

MMED's last pre-market stock price is 18.49 USD. The pre-market share volume is 27,110.00, and the stock has decreased by 0.20, or 1.09%.

What Is the MMED After Hours Price?

MMED's last after hours stock price is 18.40 USD, the stock has decreased by 0.06, or 0.33%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.